+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06656065

Study of Microvascular Resistance Index in Heart Transplant Patients During the First Year to Guide Treatment and Improve Outcomes

Led by Hospital Miguel Servet · Updated on 2025-11-21

100

Participants Needed

2

Research Sites

20 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of the index of microvascular resistance IMR to monitor heart transplant patients during their first year after surgery. The study aims to assess whether IMR can help detect acute allograft rejection and predict long-term outcomes, potentially reducing the need for invasive biopsies. This observational study follows patients undergoing heart transplantation, focusing on improving surveillance and management based on microvascular function measurements. The study involves coronary physiological assessments within the first three months and again at one year after transplant. Measurements include IMR, coronary flow reserve CFR, and fractional flow reserve FFR using a sensor-tipped guidewire in the coronary arteries. Depending on the IMR value, patient management may be adjusted, such as changing biopsy frequency or immunosuppressive therapy, although final decisions rest with the treating physician. Patients are grouped by their IMR value measured early after transplantation. Participants will be monitored through clinical evaluations, lab tests, and event tracking at one month, one year, and up to five years. Data collected includes biopsy numbers, rejection episodes, cardiac events, and therapy adjustments. All information is anonymized and securely stored in a dedicated database. The primary outcome is IMR values at three months and one year, with long-term follow-up measuring rejection, vasculopathy, mortality, and heart failure. The study seeks to improve patient care by integrating physiological measurements into post-transplant monitoring.

CONDITIONS

Brief Title

IMR-Heart Trasplant Study

Research Team

G

Georgina Fuertes, MD PHD

A

Ainhoa Perez Guerrero, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here